EAGLE PHARMACEUTICALS INC's ticker is EGRX and the CUSIP is 269796108. A total of 152 filers reported holding EAGLE PHARMACEUTICALS INC in Q4 2016. The put-call ratio across all filers is 0.87 and the average weighting 1.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $351,000 | +2.3% | 8,195 | 0.0% | 0.00% | 0.0% |
| Q1 2021 | $343,000 | -11.1% | 8,195 | -1.2% | 0.00% | -20.0% |
| Q4 2020 | $386,000 | +9.3% | 8,295 | 0.0% | 0.01% | 0.0% |
| Q3 2020 | $353,000 | -81.6% | 8,295 | -79.3% | 0.01% | -81.5% |
| Q2 2020 | $1,922,000 | +4.3% | 40,057 | 0.0% | 0.03% | -6.9% |
| Q1 2020 | $1,843,000 | -23.4% | 40,057 | 0.0% | 0.03% | +20.8% |
| Q4 2019 | $2,405,000 | +4.2% | 40,057 | -1.8% | 0.02% | -4.0% |
| Q3 2019 | $2,309,000 | +1.6% | 40,802 | 0.0% | 0.02% | 0.0% |
| Q2 2019 | $2,272,000 | +7.6% | 40,802 | -2.4% | 0.02% | +8.7% |
| Q1 2019 | $2,112,000 | +25.3% | 41,826 | 0.0% | 0.02% | +4.5% |
| Q4 2018 | $1,686,000 | -41.9% | 41,826 | 0.0% | 0.02% | -21.4% |
| Q3 2018 | $2,900,000 | -8.4% | 41,826 | 0.0% | 0.03% | -9.7% |
| Q2 2018 | $3,165,000 | +43.6% | 41,826 | 0.0% | 0.03% | +34.8% |
| Q1 2018 | $2,204,000 | -7.9% | 41,826 | -6.7% | 0.02% | 0.0% |
| Q4 2017 | $2,394,000 | -11.3% | 44,824 | -0.9% | 0.02% | +4.5% |
| Q3 2017 | $2,698,000 | -26.8% | 45,233 | -3.1% | 0.02% | -29.0% |
| Q2 2017 | $3,684,000 | -4.9% | 46,700 | 0.0% | 0.03% | -6.1% |
| Q1 2017 | $3,873,000 | -0.1% | 46,700 | -4.5% | 0.03% | +3.1% |
| Q4 2016 | $3,878,000 | -7.8% | 48,883 | -18.7% | 0.03% | -3.0% |
| Q3 2016 | $4,207,000 | +42.1% | 60,098 | -21.2% | 0.03% | +32.0% |
| Q2 2016 | $2,960,000 | -4.2% | 76,298 | 0.0% | 0.02% | -13.8% |
| Q1 2016 | $3,090,000 | -54.3% | 76,298 | 0.0% | 0.03% | -55.4% |
| Q4 2015 | $6,765,000 | +60.0% | 76,298 | +33.6% | 0.06% | +47.7% |
| Q3 2015 | $4,227,000 | -8.4% | 57,097 | 0.0% | 0.04% | -22.8% |
| Q2 2015 | $4,617,000 | – | 57,097 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JW Asset Management, LLC | 475,755 | $25,068,000 | 24.71% |
| Hudson Executive Capital LP | 971,000 | $51,162,000 | 15.09% |
| Park West Asset Management LLC | 1,051,274 | $55,392,000 | 2.47% |
| U S GLOBAL INVESTORS INC | 19,200 | $1,012,000 | 0.62% |
| Capital Impact Advisors, LLC | 26,317 | $1,387,000 | 0.57% |
| CLARK ESTATES INC/NY | 56,278 | $2,965,000 | 0.47% |
| IRIDIAN ASSET MANAGEMENT LLC/CT | 873,131 | $46,005,000 | 0.41% |
| ProQuest Associates IV LLC | 6,777 | $357,000 | 0.41% |
| Granite Investment Partners, LLC | 114,207 | $6,017,000 | 0.40% |
| GLOBEFLEX CAPITAL L P | 30,900 | $1,628,000 | 0.34% |